Radiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinoma

World Journal of Gastroenterology

Volumn 11, Issue 33, 2005, Pages 5239-5240

  Zgodzinski, Witold ^a   Espat, N Joseph ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cholangiocarcinoma; Hepatic tumor; Radiofrequency ablation

Indexed keywords

CYTOKERATIN 7;

AGED; ANAMNESIS; ARTICLE; BILE DUCT CARCINOMA; CANCER LOCALIZATION; CASE REPORT; ECHOGRAPHY; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; IMMUNOREACTIVITY; INCIDENTAL FINDING; LAPAROSCOPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY ABLATION; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 26244441151     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. American cancer society. What are the key statistics for bile duct cancer? Available at: www.cancer.org
2. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-125
3. Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 1-8
4. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232: 381-391
5. Allgaier HP, Deibert P, Zuber I, Olschewski M, Blum HE. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 1999; 353: 1676-1677